Amir A Schricker, MD
Cardiac Electrophysiology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 14
Offices
14 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Schricker’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A107058 · Current
Licensed to practise in California · since 2009 · expires 2027-03-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$406,369
Medicare paid this office $406,369 for 1,685 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 72 | $56,200 | $759 |
| Long return visit (40+ min) | 306 | $55,891 | $156 |
| Repair of left upper heart chamber with implant with review by radiologist | 77 | $30,742 | $399 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 57 | $25,928 | $252 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $18,660 | $104 |
See all 31 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 72 | $56,200 | $759 |
| Long return visit (40+ min) | 306 | $55,891 | $156 |
| Repair of left upper heart chamber with implant with review by radiologist | 77 | $30,742 | $399 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 57 | $25,928 | $252 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $18,660 | $104 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 71 | $16,491 | $226 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 952 | $16,266 | $13 |
| Return visit (30+ min) | 150 | $16,164 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 95 | $15,215 | $149 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 289 | $14,914 | $22 |
| New patient visit (60+ min) | 63 | $12,988 | $206 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 221 | $12,804 | $24 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 42 | $11,643 | $243 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 61 | $8,576 | $138 |
| Critical care, first 30-74 minutes | 25 | $7,908 | $184 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,490 | $416 |
| Programming of dual lead pacemaker system | 88 | $7,201 | $76 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $5,820 | $529 |
| Insertion of permanent leadless pacemaker using imaging guidance | 16 | $5,256 | $328 |
| Programming of heart rhythm stimulation after drug infusion | 85 | $4,904 | $56 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 69 | $4,471 | $29 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 15 | $3,472 | $72 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $3,191 | $103 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 338 | $3,147 | $7 |
| Programming of single lead pacemaker system | 44 | $3,046 | $62 |
| Ultrasound of heart, follow-up | 117 | $2,590 | $22 |
| Programming of dual lead implantable defibrillator system | 18 | $1,998 | $95 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,339 | $103 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 69 | $1,035 | $15 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 31 | $674 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 31 | $388 | $13 |
Procedures Medicare counted
| Pacemaker insertion or repair | 54 | More than 91% of doctors who do this |
Who their Medicare patients are
1,685 Original Medicare patients in 2024. Average age 79 · Under 65 2% · 85 and older 25% · Women 49% · Also on Medicaid 10% · Health risk score 1.59. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 58% · Coronary heart disease 44% · Heart failure 41% · Chronic kidney disease 35% · Diabetes 34% · Cancer 19% · Depression 17% · COPD 15% · Stroke 10% · Dementia 8%.
The office billed $2,144,698, Medicare allowed $528,688 and paid $406,369; for 5,257 services of 74 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,685 | 5,257 | 79 | 1.59 | $2,144,698 | $406,369 |
| 2023 | 1,059 | 3,762 | 79 | 1.63 | $1,462,921 | $303,264 |
| 2022 | 1,012 | 3,947 | 79 | 1.72 | $1,648,923 | $355,228 |
| 2021 | 1,050 | 3,434 | 78 | 1.68 | $1,247,144 | $291,526 |
| 2020 | 977 | 3,095 | 78 | 1.77 | $1,098,387 | $240,700 |
| 2019 | 1,280 | 2,985 | 78 | 1.81 | $1,107,275 | $234,476 |
| 2018 | 1,021 | 2,512 | 78 | 1.82 | $859,319 | $201,211 |
| 2017 | 679 | 1,226 | 73 | 2.79 | $283,902 | $66,629 |
| 2016 | 514 | 951 | 71 | 2.48 | $252,324 | $56,645 |
| 2015 | 95 | 183 | 73 | 2.27 | $89,957 | $20,028 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 34 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 55 | $45,309 | $795 |
| Long return visit (40+ min) | 191 | $31,653 | $151 |
| Return visit (30+ min) | 215 | $24,815 | $109 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 308 | $17,416 | $22 |
| New patient visit (60+ min) | 82 | $15,819 | $193 |
| Repair of left upper heart chamber with implant with review by radiologist | 38 | $15,517 | $408 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 240 | $14,944 | $24 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 91 | $13,693 | $146 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 55 | $13,192 | $231 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 26 | $8,269 | $258 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 49 | $7,320 | $144 |
| Critical care, first 30-74 minutes | 29 | $7,035 | $185 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $5,700 | $407 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $5,342 | $105 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 69 | $4,895 | $29 |
| Programming of heart rhythm stimulation after drug infusion | 62 | $4,851 | $76 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 284 | $4,278 | $13 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 24 | $4,257 | $59 |
| Telephone medical discussion with physician, 21-30 minutes | 36 | $3,498 | $95 |
| New patient visit (45+ min) | 23 | $3,245 | $141 |
| Removal and replacement of dual lead permanent pacemaker | 12 | $3,084 | $257 |
| Programming of dual lead pacemaker system | 33 | $2,790 | $80 |
| Short return visit (20+ min) | 29 | $2,203 | $76 |
| Ultrasound of heart, follow-up | 91 | $2,117 | $22 |
| Programming of single lead pacemaker system | 23 | $1,698 | $61 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 24 | $1,472 | $21 |
| Programming of dual lead implantable defibrillator system | 11 | $1,073 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 102 | $927 | $7 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 39 | $897 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $842 | $70 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 25 | $575 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 37 | $474 | $12 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 16 | $302 | $13 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $249 | $23 |
2022: 36 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 66 | $62,407 | $931 |
| Long return visit (40+ min) | 149 | $25,185 | $158 |
| Return visit (30+ min) | 218 | $24,591 | $107 |
| New patient visit (60+ min) | 100 | $18,926 | $189 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 326 | $18,815 | $22 |
| Repair of left upper heart chamber with implant with review by radiologist | 42 | $17,271 | $411 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 248 | $15,474 | $24 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $14,889 | $169 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 54 | $12,999 | $236 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 33 | $10,569 | $264 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 66 | $9,835 | $147 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 16 | $9,532 | $596 |
| Short return visit (20+ min) | 129 | $9,265 | $71 |
| Insertion of permanent leadless pacemaker using imaging guidance | 23 | $8,230 | $358 |
| Programming of heart rhythm stimulation after drug infusion | 84 | $8,152 | $96 |
| Critical care, first 30-74 minutes | 30 | $6,497 | $171 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 78 | $5,807 | $30 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $4,803 | $91 |
| Telephone medical discussion with physician, 21-30 minutes | 41 | $4,255 | $101 |
| New patient visit (45+ min) | 28 | $4,172 | $149 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 12 | $3,963 | $264 |
| Programming of dual lead pacemaker system | 39 | $3,134 | $73 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,614 | $119 |
| Ultrasound of heart, follow-up | 97 | $2,260 | $22 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 32 | $2,244 | $23 |
| Programming of single lead pacemaker system | 30 | $2,189 | $61 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 31 | $2,049 | $22 |
| External shock to heart to regulate heart beat | 20 | $1,861 | $93 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 54 | $1,359 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 77 | $1,134 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 135 | $1,128 | $7 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $977 | $75 |
| Heart rhythm recording of continous external ekg over 8-15 days | 52 | $807 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $757 | $63 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $255 | $23 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 15 | $205 | $14 |
2021: 38 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 48 | $42,376 | $883 |
| Long return visit (40+ min) | 113 | $19,993 | $153 |
| New patient visit (60+ min) | 98 | $19,346 | $197 |
| Repair of left upper heart chamber with implant with review by radiologist | 40 | $17,041 | $426 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 62 | $15,374 | $237 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 244 | $14,251 | $25 |
| Return visit (30+ min) | 103 | $12,491 | $112 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 206 | $12,284 | $25 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $12,006 | $174 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 16 | $11,798 | $655 |
| Telephone medical discussion with physician, 21-30 minutes | 95 | $9,116 | $87 |
| Short return visit (20+ min) | 117 | $9,079 | $77 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 21 | $8,217 | $342 |
| Programming of heart rhythm stimulation after drug infusion | 66 | $7,453 | $108 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $5,838 | $417 |
| Insertion of permanent leadless pacemaker using imaging guidance | 13 | $5,149 | $396 |
| Critical care, first 30-74 minutes | 23 | $5,085 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $4,617 | $92 |
| Removal and replacement of dual lead permanent pacemaker | 11 | $3,341 | $304 |
| Telephone medical discussion with physician, 11-20 minutes | 44 | $2,892 | $66 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 38 | $2,517 | $28 |
| Programming of dual lead pacemaker system | 34 | $2,466 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 280 | $2,442 | $7 |
| External shock to heart to regulate heart beat | 23 | $2,388 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $2,376 | $64 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 92 | $2,286 | $24 |
| New patient visit (45+ min) | 17 | $2,209 | $130 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,940 | $121 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 33 | $1,777 | $24 |
| Programming of single lead pacemaker system | 26 | $1,754 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 108 | $1,732 | $14 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 20 | $1,732 | $79 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 32 | $1,662 | $23 |
| Ultrasound of heart, follow-up | 65 | $1,554 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 88 | $1,420 | $16 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 15 | $547 | $36 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 15 | $348 | $23 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 12 | $168 | $14 |
2020: 35 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 38 | $32,695 | $860 |
| Telephone medical discussion with physician, 21-30 minutes | 126 | $14,210 | $99 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 219 | $13,098 | $26 |
| Return visit (30+ min) | 110 | $11,811 | $90 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 50 | $11,689 | $229 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $11,687 | $174 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 186 | $11,457 | $26 |
| Critical care, first 30-74 minutes | 34 | $9,306 | $190 |
| Long return visit (40+ min) | 70 | $8,683 | $113 |
| Repair of left upper heart chamber with implant with review by radiologist | 18 | $8,565 | $476 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $8,325 | $640 |
| Insertion of permanent leadless pacemaker using imaging guidance | 19 | $7,356 | $387 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 18 | $7,138 | $357 |
| Programming of heart rhythm stimulation after drug infusion | 50 | $6,398 | $125 |
| New patient visit (60+ min) | 38 | $5,917 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $5,358 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 213 | $3,604 | $16 |
| Short return visit (20+ min) | 58 | $3,537 | $61 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 34 | $2,660 | $34 |
| External ekg recording for more than 48 hours up to 21 days | 82 | $2,215 | $27 |
| Programming of dual lead pacemaker system | 32 | $2,182 | $64 |
| Telephone medical discussion with physician, 11-20 minutes | 31 | $2,178 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 239 | $2,110 | $7 |
| External shock to heart to regulate heart beat | 22 | $2,094 | $95 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 16 | $1,991 | $24 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 82 | $1,960 | $24 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 18 | $1,922 | $24 |
| New patient visit (45+ min) | 15 | $1,720 | $115 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 14 | $1,278 | $91 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 14 | $1,260 | $84 |
| Programming of single lead pacemaker system | 20 | $1,185 | $54 |
| Ultrasound of heart, follow-up | 46 | $1,073 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,031 | $64 |
| Ultrasonic guidance for blood vessel access | 11 | $205 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $76 | $6 |
2019: 32 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 37 | $21,949 | $593 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $18,263 | $177 |
| Return visit (30+ min) | 162 | $17,232 | $90 |
| New patient visit (60+ min) | 79 | $14,478 | $183 |
| Long return visit (40+ min) | 84 | $11,465 | $122 |
| Critical care, first 30-74 minutes | 37 | $9,804 | $192 |
| Short return visit (20+ min) | 138 | $9,122 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $8,554 | $91 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 47 | $8,392 | $175 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $8,220 | $457 |
| Repair of left upper heart chamber with implant with review by radiologist | 17 | $7,231 | $425 |
| Insertion of permanent leadless pacemaker using imaging guidance | 17 | $6,950 | $409 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $6,712 | $610 |
| Programming of dual lead pacemaker system | 96 | $6,570 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 578 | $5,974 | $8 |
| Programming of heart rhythm stimulation after drug infusion | 41 | $5,119 | $119 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 231 | $3,987 | $16 |
| New patient visit (45+ min) | 30 | $3,570 | $119 |
| External ekg recording for more than 48 hours up to 21 days | 102 | $2,722 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 101 | $2,378 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,803 | $64 |
| External shock to heart to regulate heart beat | 18 | $1,772 | $93 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 23 | $1,636 | $68 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 17 | $1,569 | $87 |
| Programming of single lead pacemaker system | 28 | $1,296 | $42 |
| Ultrasound of heart, follow-up | 55 | $1,292 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 38 | $1,147 | $22 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $975 | $81 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 22 | $845 | $22 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 23 | $528 | $23 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 23 | $476 | $12 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $407 | $29 |
2018: 36 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 37 | $16,174 | $426 |
| Long return visit (40+ min) | 88 | $11,686 | $127 |
| Return visit (30+ min) | 98 | $11,292 | $94 |
| New patient visit (45+ min) | 76 | $10,170 | $134 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 21 | $9,594 | $436 |
| New patient visit (60+ min) | 52 | $9,070 | $174 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 45 | $7,195 | $156 |
| Programming of dual lead pacemaker system | 93 | $7,114 | $52 |
| Critical care, first 30-74 minutes | 28 | $7,063 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $6,997 | $89 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 47 | $5,866 | $117 |
| Short return visit (20+ min) | 69 | $4,867 | $63 |
| Repair of left upper heart chamber with implant with review by radiologist | 18 | $4,270 | $237 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,047 | $169 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 396 | $3,794 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $3,576 | $63 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 29 | $2,674 | $86 |
| External ekg recording for more than 48 hours up to 21 days | 96 | $2,643 | $27 |
| Programming of heart rhythm stimulation after drug infusion | 23 | $2,353 | $98 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 97 | $2,328 | $23 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 37 | $2,090 | $54 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 11 | $2,061 | $187 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 107 | $1,945 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 23 | $1,835 | $76 |
| Programming of single lead pacemaker system | 27 | $1,640 | $43 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 20 | $1,423 | $44 |
| Ultrasound of heart, follow-up | 56 | $1,397 | $22 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,393 | $77 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 17 | $1,362 | $76 |
| External shock to heart to regulate heart beat | 13 | $1,355 | $97 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 26 | $1,196 | $22 |
| Programming of single lead implantable defibrillator system | 15 | $1,063 | $53 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 26 | $637 | $12 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 28 | $609 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 16 | $530 | $25 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 14 | $504 | $22 |
2017: 25 services
| Critical care, first 30-74 minutes | 20 | $6,233 | $195 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,735 | $441 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 387 | $3,588 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $3,239 | $93 |
| New patient visit (45+ min) | 20 | $2,975 | $149 |
| New patient visit (60+ min) | 15 | $2,820 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $2,621 | $61 |
| Long return visit (40+ min) | 17 | $2,275 | $134 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,990 | $166 |
| Return visit (30+ min) | 18 | $1,931 | $92 |
| Return visit (30+ min) | 29 | $1,830 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,426 | $119 |
| Long return visit (40+ min) | 12 | $1,110 | $85 |
| Short return visit (20+ min) | 23 | $952 | $34 |
| Programming of dual lead pacemaker system | 12 | $799 | $53 |
| External ekg recording for more than 48 hours up to 21 days | 28 | $790 | $28 |
| Short return visit (20+ min) | 11 | $748 | $62 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 28 | $682 | $24 |
| Programming of dual lead pacemaker system | 15 | $647 | $32 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 23 | $469 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 12 | $443 | $23 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 11 | $415 | $38 |
| Ultrasound of heart, follow-up | 13 | $324 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $260 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 25 | $184 | $7 |
2016: 13 services
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 14 | $4,483 | $320 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 364 | $3,368 | $7 |
| Critical care, first 30-74 minutes | 12 | $3,062 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $2,631 | $57 |
| Return visit (30+ min) | 33 | $2,254 | $58 |
| Short return visit (20+ min) | 31 | $1,574 | $39 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,550 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,517 | $84 |
| Hospital discharge day management, more than 30 minutes | 14 | $1,152 | $82 |
| Long return visit (40+ min) | 11 | $1,081 | $90 |
| Programming of dual lead pacemaker system | 16 | $853 | $30 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 18 | $375 | $21 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 18 | $362 | $20 |
2015: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,979 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,895 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,817 | $165 |
| Return visit (30+ min) | 12 | $766 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 21 | $146 | $7 |
Medicaid work
$23,580 in 2024
Medicaid paid $23,580 for 668 billed services this clinician did in 2024, up to 33 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 163 | $12,530 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 194 | $4,872 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 177 | $3,790 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 12 | $906 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 53 | $755 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 69 | $727 |
| 2024 | 668 | 6 | 33 | $23,580 |
| 2023 | 502 | 6 | 28 | $11,340 |
| 2022 | 449 | 6 | 28 | $10,821 |
| 2021 | 301 | 4 | 26 | $4,213 |
| 2020 | 261 | 3 | 23 | $3,658 |
| 2019 | 254 | 1 | 41 | $2,320 |
| 2018 | 207 | 1 | 42 | $2,061 |
See the largest Medicaid services in earlier years
2023
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 260 | $5,238 |
| Long return visit (40+ min) | 89 | $3,428 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 25 | $1,264 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 103 | $1,189 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 13 | $132 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 12 | $89 |
2022
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 252 | $5,105 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 52 | $2,446 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 104 | $1,654 |
| Long return visit (40+ min) | 14 | $1,001 |
| Return visit (30+ min) | 14 | $328 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 13 | $286 |
2021
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 117 | $2,290 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 100 | $1,044 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 72 | $728 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording) | 12 | $151 |
2020
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 148 | $2,622 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 64 | $590 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 49 | $446 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 254 | $2,320 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 207 | $2,061 |
Drugs they prescribed that Part D paid
$961,604
Pharmacies billed $961,604 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,593) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
890 generic and 703 brand-name prescriptions · $961,604 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 588 | $764,333 | $1,300 |
| Xarelto | 54 | $76,041 | $1,408 |
| Multaq | 21 | $47,490 | $2,261 |
| Dofetilide | 162 | $41,192 | $254 |
| Pradaxa | 14 | $3,633 | $259 |
See all 20 drugs
| Eliquis | 588 | $764,333 | $1,300 |
| Xarelto | 54 | $76,041 | $1,408 |
| Multaq | 21 | $47,490 | $2,261 |
| Dofetilide | 162 | $41,192 | $254 |
| Pradaxa | 14 | $3,633 | $259 |
| Dabigatran Etexilate | 13 | $3,018 | $232 |
| Metoprolol | 142 | $2,924 | $21 |
| Amiodarone | 67 | $2,414 | $36 |
| Flecainide Acetate | 53 | $2,183 | $41 |
| Diltiazem 24hr Er (Cd) | 48 | $2,076 | $43 |
| Sotalol Af | 41 | $1,282 | $31 |
| Sotalol | 67 | $1,209 | $18 |
| Lactated Ringers | 14 | $501 | $36 |
| Carvedilol | 32 | $398 | $12 |
| Losartan | 28 | $322 | $11 |
| Atorvastatin | 32 | $308 | $10 |
| Rosuvastatin | 11 | $241 | $22 |
| Amlodipine Besylate | 39 | $219 | $6 |
| Lisinopril | 11 | $176 | $16 |
| Metoprolol | 12 | $118 | $10 |
Year by year
| 2024 | 1,593 | 412 | 0% (0) | 44% | $961,604 |
| 2023 | 1,840 | 434 | 0% (0) | 44% | $1,105,544 |
| 2022 | 1,816 | 421 | 0% (0) | 43% | $971,078 |
| 2021 | 1,783 | 325 | None | 42% | $792,793 |
| 2020 | 1,696 | 293 | 0% (0) | 41% | $696,228 |
| 2019 | 1,666 | 265 | 0% (0) | 36% | $494,969 |
| 2018 | 1,016 | 219 | 0% (0) | 33% | $236,220 |
| 2017 | 227 | 70 | None | 39% | $46,642 |
| 2016 | 136 | 37 | 0% (0) | 33% | $18,605 |
| 2015 | 56 | 26 | None | 21% | $6,052 |
| 2014 | 42 | 21 | None | 62% | $7,936 |
| 2013 | 40 | 20 | None | 28% | $3,264 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Eliquis | 660 | $834,792 | $1,265 |
| Xarelto | 93 | $124,399 | $1,338 |
| Dofetilide | 102 | $46,890 | $460 |
| Multaq | 16 | $37,366 | $2,335 |
| Pradaxa | 15 | $8,303 | $554 |
| Metoprolol | 162 | $3,755 | $23 |
| Flecainide Acetate | 65 | $3,721 | $57 |
| Sotalol | 117 | $3,562 | $30 |
| Amiodarone | 89 | $3,100 | $35 |
| Diltiazem 24hr Er (Cd) | 49 | $2,523 | $51 |
| Sotalol Af | 36 | $1,920 | $53 |
| Carvedilol | 45 | $743 | $17 |
| Losartan | 45 | $738 | $16 |
| Atorvastatin | 41 | $681 | $17 |
| Bisoprolol | 11 | $611 | $56 |
| Amlodipine Besylate | 36 | $497 | $14 |
| Lisinopril | 15 | $285 | $19 |
| Simvastatin | 21 | $237 | $11 |
| Spironolactone | 18 | $213 | $12 |
| Metoprolol | 23 | $198 | $9 |
| Rosuvastatin | 19 | $173 | $9 |
| Furosemide | 15 | $138 | $9 |
2022: 24 drugs
| Eliquis | 626 | $714,296 | $1,141 |
| Xarelto | 88 | $123,152 | $1,399 |
| Dofetilide | 80 | $36,075 | $451 |
| Pradaxa | 29 | $26,944 | $929 |
| Multaq | 18 | $21,842 | $1,213 |
| Metoprolol | 145 | $4,113 | $28 |
| Flecainide Acetate | 46 | $3,660 | $80 |
| Amiodarone | 87 | $3,652 | $42 |
| Sotalol | 127 | $3,353 | $26 |
| Diltiazem 24hr Er (Cd) | 53 | $2,939 | $55 |
| Sotalol Af | 53 | $2,862 | $54 |
| Verapamil Er | 16 | $1,636 | $102 |
| Carvedilol | 57 | $1,230 | $22 |
| Propafenone | 13 | $1,127 | $87 |
| Losartan | 45 | $693 | $15 |
| Atorvastatin | 48 | $685 | $14 |
| Amlodipine Besylate | 36 | $460 | $13 |
| Metoprolol | 37 | $429 | $12 |
| Spironolactone | 16 | $392 | $25 |
| Furosemide | 26 | $316 | $12 |
| Potassium Chloride | 15 | $243 | $16 |
| Amlodipine Besylate-Benazepril | 12 | $206 | $17 |
| Lisinopril | 16 | $162 | $10 |
| Simvastatin | 26 | $150 | $6 |
2021: 26 drugs
| Eliquis | 589 | $601,145 | $1,021 |
| Xarelto | 107 | $118,717 | $1,110 |
| Pradaxa | 17 | $17,245 | $1,014 |
| Dofetilide | 31 | $11,766 | $380 |
| Diltiazem 24hr Er (Cd) | 45 | $5,992 | $133 |
| Metoprolol | 150 | $4,986 | $33 |
| Flecainide Acetate | 24 | $3,242 | $135 |
| Sotalol | 96 | $2,516 | $26 |
| Propafenone | 17 | $1,601 | $94 |
| Amiodarone | 49 | $1,593 | $33 |
| Verapamil Er | 16 | $1,452 | $91 |
| Carvedilol | 72 | $1,268 | $18 |
| Sotalol Af | 38 | $1,212 | $32 |
| Atorvastatin | 69 | $896 | $13 |
| Potassium Chloride | 17 | $885 | $52 |
| Losartan | 48 | $714 | $15 |
| Metoprolol | 53 | $653 | $12 |
| Amlodipine Besylate | 61 | $599 | $10 |
| Torsemide | 11 | $547 | $50 |
| Furosemide | 43 | $432 | $10 |
| Lisinopril | 36 | $422 | $12 |
| Amlodipine Besylate-Benazepril | 13 | $271 | $21 |
| Rosuvastatin | 15 | $253 | $17 |
| Spironolactone | 12 | $249 | $21 |
| Simvastatin | 30 | $179 | $6 |
| Hydrochlorothiazide | 11 | $48 | $4 |
2020: 24 drugs
| Eliquis | 462 | $484,271 | $1,048 |
| Xarelto | 109 | $122,594 | $1,125 |
| Pradaxa | 19 | $21,356 | $1,124 |
| Dofetilide | 27 | $9,129 | $338 |
| Diltiazem 24hr Er (Cd) | 40 | $8,957 | $224 |
| Metoprolol | 171 | $5,745 | $34 |
| Flecainide Acetate | 33 | $4,560 | $138 |
| Sotalol | 56 | $2,017 | $36 |
| Atorvastatin | 107 | $1,929 | $18 |
| Amiodarone | 32 | $1,508 | $47 |
| Potassium Chloride | 34 | $1,350 | $40 |
| Carvedilol | 84 | $1,177 | $14 |
| Propafenone | 16 | $1,095 | $68 |
| Sotalol Af | 20 | $1,048 | $52 |
| Verapamil Er | 11 | $998 | $91 |
| Torsemide | 21 | $850 | $40 |
| Losartan | 42 | $625 | $15 |
| Furosemide | 53 | $612 | $12 |
| Amlodipine Besylate | 59 | $543 | $9 |
| Lisinopril | 41 | $477 | $12 |
| Metoprolol | 40 | $437 | $11 |
| Atenolol | 11 | $320 | $29 |
| Simvastatin | 29 | $312 | $11 |
| Benazepril | 13 | $251 | $19 |
2019: 24 drugs
| Eliquis | 341 | $307,290 | $901 |
| Xarelto | 111 | $111,725 | $1,007 |
| Dofetilide | 27 | $13,474 | $499 |
| Pradaxa | 11 | $10,895 | $990 |
| Metoprolol | 194 | $6,668 | $34 |
| Flecainide Acetate | 60 | $5,762 | $96 |
| Diltiazem 24hr Er (Cd) | 30 | $4,209 | $140 |
| Potassium Chloride | 57 | $2,367 | $42 |
| Atorvastatin | 111 | $2,184 | $20 |
| Verapamil Sr | 11 | $1,683 | $153 |
| Sotalol | 25 | $1,085 | $43 |
| Amiodarone | 30 | $1,068 | $36 |
| Carvedilol | 81 | $971 | $12 |
| Propafenone | 13 | $865 | $67 |
| Furosemide | 82 | $859 | $10 |
| Torsemide | 24 | $854 | $36 |
| Losartan | 50 | $735 | $15 |
| Verapamil Er | 19 | $691 | $36 |
| Amlodipine Besylate | 59 | $515 | $9 |
| Simvastatin | 40 | $426 | $11 |
| Lisinopril | 37 | $387 | $10 |
| Metoprolol | 33 | $354 | $11 |
| Atenolol | 16 | $306 | $19 |
| Hydralazine | 15 | $159 | $11 |
2018: 23 drugs
| Eliquis | 170 | $129,200 | $760 |
| Xarelto | 65 | $66,586 | $1,024 |
| Dofetilide | 11 | $6,660 | $605 |
| Brilinta | 11 | $4,080 | $371 |
| Metoprolol | 104 | $3,647 | $35 |
| Flecainide Acetate | 50 | $3,163 | $63 |
| Potassium Chloride | 35 | $1,883 | $54 |
| Sotalol Af | 16 | $1,620 | $101 |
| Atorvastatin | 54 | $1,259 | $23 |
| Diltiazem 24hr Er (Cd) | 23 | $895 | $39 |
| Cartia Xt | 25 | $841 | $34 |
| Amiodarone | 22 | $635 | $29 |
| Carvedilol | 51 | $588 | $12 |
| Furosemide | 72 | $493 | $7 |
| Irbesartan | 13 | $422 | $32 |
| Hydralazine | 12 | $348 | $29 |
| Torsemide | 20 | $328 | $16 |
| Amlodipine Besylate | 33 | $286 | $9 |
| Losartan | 30 | $273 | $9 |
| Lisinopril | 24 | $216 | $9 |
| Simvastatin | 24 | $192 | $8 |
| Spironolactone | 12 | $191 | $16 |
| Metoprolol | 22 | $177 | $8 |
2017: 5 drugs
| Xarelto | 23 | $16,473 | $716 |
| Eliquis | 34 | $16,307 | $480 |
| Metoprolol | 26 | $718 | $28 |
| Amiodarone | 14 | $377 | $27 |
| Atorvastatin | 15 | $171 | $11 |
2016: 3 drugs
| Eliquis | 16 | $7,028 | $439 |
| Flecainide Acetate | 14 | $449 | $32 |
| Sotalol | 11 | $160 | $15 |
Money from drug and device companies
$2,284 in 2025
| 2025 | 6 | 24 | None | $2,284 |
| 2024 | 6 | 22 | $600 | $2,112 |
| 2023 | 7 | 50 | $6,125 | $9,700 |
| 2022 | 4 | 55 | $9,750 | $15,541 |
| 2021 | 2 | 3 | $1,500 | $1,719 |
| 2020 | 1 | 4 | None | $748 |
| 2019 | 3 | 16 | $1,250 | $2,513 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Ensite | $722 | 7 payments
|
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $704 | 6 payments
|
| Boston Scientific | Watchman Flx | $554 | 7 payments
|
| Amgen | Repatha | $140 | 1 payment
|
| Philips North America | Ambulatory Monitoring & Diagnostics Undivided | $122 | 1 payment
|
| Medtronic | Micra | $43 | 2 payments
|
See all 24 published payments
| Boston Scientific | Meals · 2025-12-11 | Watchman Flx | $131 |
| Abbott Laboratories | Meals · 2025-11-14 | Aveir | $152 |
| Amgen | Meals · 2025-10-29 | Repatha | $140 |
| Boston Scientific | Meals · 2025-09-18 | Watchman Flx | $153 |
| AtriCure | Meals · 2025-09-13 | Epi-Sense Guided Coagulation System With Visitrax | $103 |
| AtriCure | Meals · 2025-09-13 | Epi-Sense Guided Coagulation System With Visitrax | $53 |
| AtriCure | Meals · 2025-09-13 | Epi-Sense Guided Coagulation System With Visitrax | $89 |
| AtriCure | Meals · 2025-09-12 | Epi-Sense Guided Coagulation System With Visitrax | $175 |
| Boston Scientific | Meals · 2025-07-24 | Watchman Flx | $97 |
| Boston Scientific | Meals · 2025-07-21 | Watchman Flx | $10 |
| Medtronic | Meals · 2025-07-16 | Micra | $21 |
| Abbott Laboratories | Meals · 2025-07-10 | Aveir | $137 |
| Abbott Laboratories | Meals · 2025-06-25 | Ensite | $116 |
| Abbott Laboratories | Meals · 2025-06-18 | Amplatzer Talisman | $25 |
| Abbott Laboratories | Meals · 2025-05-06 | Ensite | $163 |
| AtriCure | Meals · 2025-04-24 | Epi-Sense Guided Coagulation System With Visitrax | $148 |
| Abbott Laboratories | Meals · 2025-04-21 | Amplatzer Amulet | $110 |
| Boston Scientific | Meals · 2025-04-18 | Farapulse | $58 |
| Boston Scientific | Meals · 2025-04-18 | Farapulse | $39 |
| Philips North America | Meals · 2025-04-11 | Ambulatory Monitoring & Diagnostics Undivided | $122 |
| AtriCure | Meals · 2025-03-20 | Epi-Sense Guided Coagulation System With Visitrax | $136 |
| Boston Scientific | Meals · 2025-03-18 | Farapulse | $67 |
| Medtronic | Meals · 2025-03-07 | Micra | $22 |
| Abbott Laboratories | Meals · 2025-01-20 | Ensite | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,112
| Abbott Laboratories | Aveir | $758 | 9 payments
|
| Sobi | Vonjo | $600 | 1 payment
|
| Boston Scientific | Watchman Flx | $358 | 7 payments
|
| Medtronic | Micra | $176 | 3 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $149 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $70 | 1 payment
|
2023: $9,700
| Medtronic | Micra | $6,706 | 27 payments
|
| AltaThera Pharmaceuticals | Sotalol Hydrochloride | $1,791 | 3 payments
|
| Abbott Laboratories | Ensite | $523 | 11 payments
|
| Philips Electronics North America | (5044) Mcot | $172 | 2 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $172 | 1 payment
|
| Boston Scientific | Watchman Access System | $171 | 2 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $164 | 2 payments
|
2022: $15,541
| Medtronic | Micra | $11,280 | 22 payments
|
| Abbott Laboratories | Ensite Precision | $4,140 | 31 payments
|
| Philips Electronics North America | (5044) Mcot | $102 | 1 payment
|
| Boston Scientific | Watchman Access System | $19 | 1 payment
|
2021: $1,719
| Medtronic | Micra | $1,600 | 2 payments
|
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $119 | 1 payment
|
2020: $748
| Boston Scientific | Watchman | $748 | 4 payments
|
2019: $2,513
| Medtronic Vascular | 3f | $1,585 | 6 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $704 | 8 payments
|
| Biotronik | None | $224 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| ATRICURE, INC. · Atricure Incoraf Retro · 2024 | Their institution | $4,000 |
Professional record
- NPI
- 1023214798
- Licence
- CA A107058California A107058: Current · expires 2027-03-31
- Trained
- University of Southern California Keck School of Medicine, 2007
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2007-06-21
- NPI last updated
- 2023-06-07
- NPI record certified
- 2023-06-07
This is when the NPI record was last certified, not a medical board exam.